BrainCheck

Country:
USA
Founding year:
2014

BrainCheck is a neurotechnology company developing a digital cognitive assessment platform designed to objectively measure cognitive function across multiple domains. The software delivers standardized tests via tablets and web-based interfaces to support fast, repeatable cognitive screening outside of traditional neuropsychological settings.

The platform uses validated assessment tasks and automated scoring algorithms to evaluate memory, attention, executive function, and processing speed. Results are generated in real time and presented through clinician-facing dashboards that support longitudinal tracking, remote administration, and integration into care workflows.

BrainCheck is deployed in clinical, emergency, sports, and aging-related care contexts, including concussion assessment, dementia screening, and routine cognitive monitoring. The company positions its software as an accessible diagnostic support tool that expands cognitive assessment beyond specialist settings while maintaining clinical rigor.

Cognitive and Mental Health
Diagnostics
Clinical Workflows

Neurofounders Insights

Modality:
Software
Form Factor:
Software/app
Interface Depth:
Software
Indication:
Dementia/impairment
Target user:
Patients
Regulatory stage:
FDA cleared (501k)

Series A

BrainCheck is positioned as a software-only cognitive screening platform with FDA clearance, targeting rapid in-clinic assessment across dementia, concussion, and general cognitive decline without requiring specialized neuropsychological staff. Its differentiation lies in clinical workflow integration and regulatory status rather than novel biomarker technology, placing it in the digital cognitive assessment tier alongside Cogstate and Cambridge Cognition.

Related companies

Articles featuring

BrainCheck

No articles yet!

Press releases

No press releases published yet.